Chinese guidelines for diagnosis and treatment of prostate cancer 2018 (English version).
出版信息
Chin J Cancer Res. 2019 Feb;31(1):67-83. doi: 10.21147/j.issn.1000-9604.2019.01.04.
Abstract
摘要
相似文献
1
Chinese guidelines for diagnosis and treatment of prostate cancer 2018 (English version).
Chin J Cancer Res. 2019 Feb;31(1):67-83. doi: 10.21147/j.issn.1000-9604.2019.01.04.
2
Psychometric Assessment of the Chinese Version of the Abbreviated Expanded Prostate Cancer Index Composite (EPIC-26) and the Clinical Practice Version (EPIC-CP) in Chinese Men With Prostate Cancer.
J Pain Symptom Manage. 2017 Jun;53(6):1085-1090. doi: 10.1016/j.jpainsymman.2017.02.010. Epub 2017 Apr 22.
3
Chinese guidelines for diagnosis and treatment of pancreatic cancer 2018 (English version).
Chin J Cancer Res. 2019 Apr;31(2):278-294. doi: 10.21147/j.issn.1000-9604.2019.02.03.
4
Chinese guidelines for diagnosis and treatment of cervical cancer 2018 (English version).
Chin J Cancer Res. 2019 Apr;31(2):295-305. doi: 10.21147/j.issn.1000-9604.2019.02.04.
5
Chinese guidelines for diagnosis and treatment of gastric cancer 2018 (English version).
Chin J Cancer Res. 2019 Oct;31(5):707-737. doi: 10.21147/j.issn.1000-9604.2019.05.01.
6
Chinese guidelines for diagnosis and treatment of breast cancer 2018 (English version).
Chin J Cancer Res. 2019 Apr;31(2):259-277. doi: 10.21147/j.issn.1000-9604.2019.02.02.
7
Chinese guidelines for diagnosis and treatment of primary lung cancer 2018 (English version).
Chin J Cancer Res. 2019 Feb;31(1):1-28. doi: 10.21147/j.issn.1000-9604.2019.01.01.
8
Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for colorectal cancer 2018 (English version).
Chin J Cancer Res. 2019 Feb;31(1):117-134. doi: 10.21147/j.issn.1000-9604.2019.01.07.
9
Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for head and neck cancer 2018 (English version).
Chin J Cancer Res. 2019 Feb;31(1):84-98. doi: 10.21147/j.issn.1000-9604.2019.01.05.
10
Equivalence of Chinese and US-English versions of the SF-36 health survey.
Qual Life Res. 2003 Jun;12(4):449-57. doi: 10.1023/a:1023446110727.
引用本文的文献
1
SLX1 silencing overcomes Olaparib resistance in metastatic castration-resistant prostate cancer by disrupting SLX4-mediated DNA repair complexes.
Cancer Biol Ther. 2025 Dec;26(1):2545062. doi: 10.1080/15384047.2025.2545062. Epub 2025 Aug 11.
2
Patient, caregiver experiences in metastatic castration-resistant prostate cancer: insights from a multi-national survey.
Future Oncol. 2025 Jul;21(16):2053-2066. doi: 10.1080/14796694.2025.2510890. Epub 2025 Jun 2.
3
LncRNA LINC01128 promotes prostate cancer cell proliferation, metastasis, and epithelial-mesenchymal transition by modulating miR-27b-3p.
J Cancer Res Clin Oncol. 2025 Mar 4;151(3):98. doi: 10.1007/s00432-025-06153-6.
4
Effectiveness and economic outcomes in patients undergoing laparoscopic radical prostatectomy with a new surgical shear with an integrated energy system: A retrospective study based on a tertiary hospital database in China.
Asian J Urol. 2024 Oct;11(4):563-568. doi: 10.1016/j.ajur.2023.08.010. Epub 2024 May 7.
5
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with prostate cancer.
ESMO Open. 2022 Aug;7(4):100518. doi: 10.1016/j.esmoop.2022.100518. Epub 2022 Jul 4.
6
Recommendations on Weight Loss and Healthy Lifestyle in Prostate Cancer Clinical Guidelines: A Systematic Review.
Int J Environ Res Public Health. 2022 Jan 27;19(3):1452. doi: 10.3390/ijerph19031452.
7
Peripheral zone PSA density: a predominant variable to improve prostate cancer detection efficiency in men with PSA higher than 4 ng ml.
Asian J Androl. 2021 Jul-Aug;23(4):415-420. doi: 10.4103/aja.aja_72_20.
8
Continuous poliglecaprone suture versus bidirectional barded suture for urethrovesical anastomosis during laparoscopic radical prostatectomy: a single-institute retrospective analysis of Chinese patients.
Gland Surg. 2020 Oct;9(5):1305-1312. doi: 10.21037/gs-20-371.
9
Bruton's Tyrosine Kinase (BTK) Inhibitor (Ibrutinib)-Suppressed Migration and Invasion of Prostate Cancer.
Onco Targets Ther. 2020 May 13;13:4113-4122. doi: 10.2147/OTT.S245848. eCollection 2020.
10
Metabolically Abnormal Obesity Increases the Risk of Advanced Prostate Cancer in Chinese Patients Undergoing Radical Prostatectomy.
Cancer Manag Res. 2020 Mar 10;12:1779-1787. doi: 10.2147/CMAR.S242193. eCollection 2020.
Zotero 插件